Trial to investigate a new preventive treatment for migraine

What is the purpose of the study?

This study is for a new preventive investigational treatment for migraine and the impact it has on reducing the number of migraine attacks experienced in a typical month.

Who can take part?

  • Aged 18 years and over
  • Has frequent migraine attacks

What will the study involve?

 The study will involve regularly taking the study treatment orally over the course of the study.

The study will run for approximately 36 weeks and will include regular visits to a clinic in Glasgow.

Where does the study take place?

At CPS Research, which is based in Glasgow, Scotland. Participants will be reimbursed for reasonable travel and inconvenience expenses for each visit.

How to take part?

 Please fill out the short online screening questionnaire to see if you may be eligible here.

Alternatively, please call the CPS Research clinic on 0141 946 7888.